A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Matrix Biology

• Publication date

  2003-12-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MATBIO.2003.10.004PMID 14996438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparison of bayesian methods for haplotype reconstruction from population genotype data.

  2003cited by this paper
• Matrix metalloproteinases: a therapeutic target in cardiovascular disease.

  2003cited by this paper
• Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?

  2002cited by this paper
• Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.

  2002cited by this paper
• Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering

  2002cited by this paper
• Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis.

  2001cited by this paper
• Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis

  2001cited by this paper
• Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques: Implications for Plaque Stabilization

  2001cited by this paper
• Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 Gene

  2001cited by this paper
• A new statistical method for haplotype reconstruction from population data.

  2001cited by this paper
• Activation of metalloproteinase-2, loss of matrix scleroprotein content and coronary artery calcification.

  2001cited by this paper
• Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels

  2001cited by this paper
• Expression of matrix metalloproteinases in patients with acute myocardial infarction.

  2001cited by this paper
• Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery.

  2000cited by this paper
• Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency.

  2000cited by this paper
• Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

  1999cited by this paper
• Strategies to achieve coronary arterial plaque stabilization.

  1999cited by this paper
• Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.

  1998cited by this paper
• Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.

  1998cited by this paper
• Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.

  1996cited by this paper
• Structure of the human type IV collagenase gene.

  1990cited by this paper
• The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes.

  1988cited by this paper

• The rs243865 Polymorphism in Matrix Metalloproteinase-2 and its Association With Target Organ Damage in Patients With Resistant Hypertension: Cross-Sectional Study

  2025cites this paper
• MMP2 and MMP9 are associated with the pathogenesis of recurrent pregnancy loss through protein expression rather than genetic polymorphism.

  2024cites this paper
• Functional relevance of MMP2 promoter variants in gallbladder cancer: A case-control study in an Eastern Indian Population.

  2024cites this paper
• SNP-SNP positive interaction between MMP2 and MMP12 increases the risk of COPD

  2024cites this paper
• Association of matrix metalloproteinase‐2 gene variants with diabetic nephropathy risk

  2023cites this paper
• Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque

  2022cites this paper
• Association of MMP-2 genes variants with diabetic retinopathy in Tunisian population with type 2 diabetes.

  2022cites this paper
• Matrix metalloproteinase-2 and angiotensin-1 gene polymorphisms in patient who have coronary artery disease

  2021cites this paper
• TT genotype of the MMP‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke

  2021cites this paper
• Gene variability in matrix metalloproteinases in patients with recurrent aphthous stomatitis.

  2020cites this paper
• Myocardial Basis for Heart Failure

  2020cites this paper
• Asociace polymorfizmů v genu pro matrix metalloproteinázu-2 a tkáňový inhibitor metalloproteinázy-2 s roztroušenou sklerózou an association between Matrix Metalloproteinase-2 and tiMp-2 + 853 g / a gene polymorphisms and Multiple sclerosis

  2019cites this paper
• MMP2 Polymorphism Affects Plasma Matrix Metalloproteinase (MMP)-2 Levels, and Correlates with the Decline in Lung Function in Hypersensitivity Pneumonitis Positive to Autoantibodies Patients

  2019cites this paper
• Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.

  2017cites this paper
• Cardiovascular Risk and Matrix Metalloproteinase Polymorphisms: Not Just a Simple Substitution.

  2017cites this paper
• Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges.

  2017cites this paper
• Association between matrix metaloproteinases 2-1306C/T polymorphism and the risk of coronary artery disease in Iranian population.

  2017cites this paper
• Overview of MMP Biology and Gene Associations in Human Diseases

  2017cites this paper
• Matrix metalloproteinase-2 -735C/T polymorphism is associated with resistant hypertension in a specialized outpatient clinic in Brazil.

  2017cites this paper
• Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction

  2017cites this paper
• Evaluation of MMP-7 A-181G and MMP-2 C-735T polymorphisms in healthy population from western Iran.

  2016influential citation
• [Expressions of inflammatory and fibrogenic factors in perinephric and subcutaneous adipose tissues of patients with adrenocorticotropic hormone-independent Cushing's syndrome].

  2016cites this paper
• Relationship between single-nucleotide polymorphism of matrix metalloproteinase-2 gene and colorectal cancer and gastric cancer susceptibility: a meta-analysis

  2015cites this paper
• MMP2 gene-735 C/T and MMP9 gene -1562 C/T polymorphisms in JAK2V617F positive myeloproliferative disorders.

  2015cites this paper
• Genetic polymorphisms of matrix metalloproteinases and protein levels in chronic obstructive pulmonary disease in a Mexican population.

  2015cites this paper
• Matrix metalloproteinase-2 (MMP-2) gene polymorphism and cardiovascular comorbidity in type 2 diabetes patients.

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Patients With Chronic Three-Vessel Disease in a 15-Year Follow-Up Study

  2014cites this paper
• LAMP Genetic susceptibility factors in endometriosis

  2013cites this paper
• Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.

  2012cites this paper
• Genetic Causation of Neointimal Hyperplasia in Hemodialysis Vascular Access Dysfunction

  2012cites this paper
• Matrix metalloproteinase family gene polymorphisms and risk for coronary artery disease: systematic review and meta-analysis

  2012cites this paper
• Matrix Metalloproteinase 13 Genotype in rs640198 Polymorphism Is Associated with Severe Coronary Artery Disease

  2012cites this paper
• Genetic variability of matrix metalloproteinase genes in cardiovascular disease.

  2012cites this paper
• Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients

  2012cites this paper
• The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients.

  2012cites this paper
• Genotype association of C(-735)T polymorphism of the MMP-2 gene with the risk of carotid atherosclerosis-vulnerable plaque in the Han Chinese population

  2011cites this paper
• MMP2 gene polymorphisms and MMP2 mRNA levels in patients with superficial varices of lower extremities.

  2011cites this paper
• Analysis of MMP2 promoter polymorphisms in childhood obesity

  2011cites this paper
• Matrix Metalloproteinases 2 and 3 Gene Polymorphisms and the Risk of Target Vessel Revascularization after Percutaneous Coronary Intervention: Is There Still Room for Determining Genetic Variation of MMPs for Assessment of an Increased Risk of Restenosis?

  2011cites this paper
• Is a single nucleotide polymorphism a risk factor for lung cancer in the matrix metalloproteinase-2 promoter?

  2011cites this paper
• Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.

  2011cites this paper
• The Role of Matrix Metalloproteinase-2 Promoter Polymorphisms in Coronary Artery Disease and Myocardial Infarction

  2011influential citation
• Prognostic Significance of MMP 2 and MMP 9 Functional Promoter Single Nucleotide Polymorphisms in Head and Neck Squamous Cell Carcinoma

  2011cites this paper
• The Role of Matrix Metalloproteinases in Atherothrombosis

  2011cites this paper
• Chapter 5 – Myocardial Basis for Heart Failure: Role of the Cardiac Interstitium

  2011cites this paper
• PROGNOSTIC SIGNIFICANCE OF MMP2 AND MMP9 FUNCTIONAL PROMOTER SINGLE NUCLEOTIDE POLYMORPHISMS IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

  2011cites this paper
• MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study.

  2010cites this paper
• Matrix metalloproteinases in atherothrombosis.

  2010influential citation
• Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients.

  2010cites this paper
• Polymorphisms in MMP-2 and MMP-9 promoter regions are associated with endometriosis.

  2010cites this paper
• Matrix metalloproteinases 2 an 3 gene polymorphisms and the risk of target vessel revascularisation after percutaneous coronary intervention

  2010cites this paper
• Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elasticum.

  2010cites this paper
• Matrix Metalloproteinase-2 Promoter Genotype as a Marker of Cutaneous T-Cell Lymphoma Early Stage

  2010cites this paper
• Association of polymorphisms of zinc metalloproteinases with clinical response to stem cell therapy

  2010cites this paper
• Matrix metalloproteinase-2 promoter variability in psoriasis

  2009cites this paper
• Association of matrix metalloproteinase-2 gene promoter polymorphism with myocardial infarction susceptibility in a Mexican population

  2009cites this paper
• Polymorphisms of MMP-3 and TIMP-4 genes affect angiographic coronary plaque progression in non-diabetic and type 2 diabetic patients.

  2009cites this paper
• Association of (−1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms)

  2009cites this paper
• Functional Polymorphisms in the Promoter Regions of Matrix Metalloproteinase-2, -3, -7, -9 and TNF-alpha Genes, and the Risk of Colorectal Neoplasm in Japanese

  2009cites this paper
• Suppression of chemokine gene expression and production in LPS-stimulated macrophages by a 130 kDa glycoprotein from plerocercoids of Spirometra erinaceieuropaei.

  2009cites this paper
• Untersuchungen zur Pathobiochemie der extrazellulären Matrix bei Pseudoxanthoma elasticum (PXE)

  2009cites this paper
• Molecular genetics of myocardial infarction

  2008cites this paper
• Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression.

  2008cites this paper
• Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.

  2008cites this paper
• Potentiation and priming of platelet activation: a potential target for antiplatelet therapy.

  2008cites this paper
• Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy

  2008cites this paper
• Polymorphisms in MMP Family and TIMP Genes and Carotid Artery Intima-Media Thickness

  2007cites this paper
• Association of matrix metalloproteinase‐2 and ‐9 promoter polymorphisms with colorectal cancer in Chinese

  2007cites this paper
• Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.

  2007cites this paper
• Genetics of preterm labour.

  2007cites this paper
• Matrix Metalloproteinases and Their Tissue Inhibitors in Preterm Perinatal Complications

  2007cites this paper
• Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

  2007cites this paper
• The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis

  2006cites this paper
• Functional polymorphisms in the matrix metalloproteinase-9 gene in relation to severity of chronic periodontitis.

  2006cites this paper
• Matrix Metalloproteinases and Atherogenesis in Dependence of Age

  2006cites this paper
• Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome.

  2006cites this paper
• Genetic variations in the human gelatinase A (matrix metalloproteinase-2) promoter are not associated with susceptibility to, and severity of, chronic periodontitis.

  2005cites this paper
• Structural aspects of Golgi function

  2003cites this paper